2021
DOI: 10.1002/jmri.27954
|View full text |Cite
|
Sign up to set email alerts
|

An Update in Imaging Evaluation of Histopathological Grade of Soft Tissue Sarcomas Using Structural and Quantitative Imaging and Radiomics

Abstract: Over the past two decades, considerable efforts have been made to develop non‐invasive methods for determining tumor grade or surrogates for predicting the biological behavior, aiding early treatment decisions, and providing prognostic information. The development of new imaging tools, such as diffusion‐weighted imaging, diffusion kurtosis imaging, perfusion imaging, and magnetic resonance spectroscopy have provided leverage in the diagnosis of soft tissue sarcomas. Artificial intelligence is a new technology … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 71 publications
(166 reference statements)
0
3
0
Order By: Relevance
“…Recent advantages in regards of quantitative imaging may offer more precise and reliable information, in all the phases of the disease. Several quantitative tools applicable to MRI such as diffusion (DWI) sequences, dynamic contrast-enhanced, and radiomics analyses are increasing in use to obtain a solid and more reliable evaluation [ 25 , 26 ]. In the near future, the radiomic features extrapolated from MRI studies will permit to build artificial intelligence algorithms, in order to help in diagnosis, to predict patients’ prognosis and for tumor grade prediction, and to evaluate responses to treatments.…”
Section: Discussionmentioning
confidence: 99%
“…Recent advantages in regards of quantitative imaging may offer more precise and reliable information, in all the phases of the disease. Several quantitative tools applicable to MRI such as diffusion (DWI) sequences, dynamic contrast-enhanced, and radiomics analyses are increasing in use to obtain a solid and more reliable evaluation [ 25 , 26 ]. In the near future, the radiomic features extrapolated from MRI studies will permit to build artificial intelligence algorithms, in order to help in diagnosis, to predict patients’ prognosis and for tumor grade prediction, and to evaluate responses to treatments.…”
Section: Discussionmentioning
confidence: 99%
“…The investigation and application of ML to STS has lagged bone sarcoma because of a more heterogeneous appearance and fewer diagnostic characteristics. A significant proportion of the literature of ML in STS focuses on the use of radiomics for predicting tumor grade or biologic behavior 43-45 . Lee et al created an ensemble ML algorithm that used multiple sequence inputs comparisons (T1 + T2, T1 + T2 +contrast T1, T1 + T2 + diffusion weighted imaging, and all of the above), for differentiation of benign vs. soft tissue differentiation with AUC of 0.752, 0.756, 0.750, 0.749, respectively 46 .…”
Section: Applications Of Ai In Orthopaedic Oncologymentioning
confidence: 99%
“…Dynamic contrast-enhanced MRI (DCE-MRI) is being increasingly applied to obtain temporal information about tumour microvascularity and there have been a wealth of studies in the past few decades (90)(91)(92)(93)(94). It is well recognised that the tumour vascular system has an altered pathophysiology and role in tumourigenesis, supporting the diagnostic clinical application of DCE-MRI (95,96). DCE-MRI utilises serial images capturing the arrival, duration and exit of a contrast agent in a tissue of interest, generating a signal intensity curve that may provide detailed information on both the physical and physiological properties of tissue in response to the agent (91,(97)(98)(99).…”
Section: Quantitative Mrimentioning
confidence: 99%